CA Patent

CA2176712A1 — Synthetic membrane vesicles with controlled release of encapsulated biologically active substances

Assigned to Pacira Pharmaceuticals Inc · Expires 1995-05-26 · 31y expired

What this patent protects

A synthetic membrane vesicle composition containing at least one release-rate modifying agent other than a hydrohalide and at least one biologically active substance, the vesicles having defined size distribution, adjustable average size, internal chamber size and number and a co…

USPTO Abstract

A synthetic membrane vesicle composition containing at least one release-rate modifying agent other than a hydrohalide and at least one biologically active substance, the vesicles having defined size distribution, adjustable average size, internal chamber size and number and a controlled release rate of the biologically active substance. A process for making the composition features addition of a release-rate modifying agent effective to prolong, sustain, and control the rate of release from the vesicles of the biologically active substance at therapeutic levels after encapsulation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2176712A1
Jurisdiction
CA
Classification
Expires
1995-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Pacira Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.